摘要 |
The present invention is directed to compounds that are inhibitors of cystei ne proteases, in particular, cathepsins B, K, L, F, and S and are therefore useful in treating diseases mediated by these proteases. The present inventi on is directed to pharmaceutical compositions comprising these compounds and processes for preparing them.
|